At the news
? BEARISHIMPACT 6/10 CLUSTER filed Mar 3, 2026 at 19:00 ET
GeneDx CEO Katherine Stueland sold $455K in open-market shares while receiving a large non-cash stock award; CFO Kevin Feeley sold $110K and received non-cash grants. The cluster is dominated by routine compensation grants, but the CEO's open-market sale is the largest transaction and suggests potential lack of conviction.
- CEO Katherine Stueland sold 5,861 shares at $77.63, totaling $454,967 in open-market transaction
- CFO Kevin Feeley sold 1,424 shares for $110,540 in open-market trade
- CEO and CFO received substantial non-cash stock awards totaling 107,469 shares collectively, valued at $299,926 for the CEO's time-based grant
- Total open-market selling: $565,507 (CEO: $455K, CFO: $110.5K)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access